ArthroCare has reported third-quarter revenue of $86.9 million, up 4.4 percent compared to the same quarter last year.
Worldwide sales of ArthroCare's sports medicine products increased $3.1 million, or 5.9 percent. The company attributes sports medicine growth to the recent Coblation and fixation product introductions as well as increased sales of knee wands resulting from a knee initiative.
More Articles on Orthopedic Devices:
NeuroMetrix Signs Distribution Agreement for Pain Management Device
ConforMIS Moves Corporate Headquarters